在患有的患者中,与 levetiracetam 治疗同时进行的卡巴马泽平毒性
Archana Mishra1, Biswa Ranjan Mishra2, Debadatta Mohapatra2
1Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.
The International journal of neuroscience
|April 5, 2025
概括
levetiracetam (LEV) 与卡巴马西平 (CBZ) 的同时使用显著增加了CBZ毒性的风险. 1.86或更高的LEV与CBZ剂量比率与有毒的CBZ水平有关.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 药物相互作用 药物相互作用
背景情况:
- 药物相互作用对于抗药物的有效性和安全性至关重要.
- 了解卡巴马泽平 (CBZ) 和 levetiracetam (LEV) 之间的相互作用是必不可少的.
研究的目的:
- 为了研究CBZ和LEV之间的药物相互作用.
- 为了确定与CBZ毒性相关的因素.
主要方法:
- 一项对158名患者的病例控制研究.
- 进行了单变量和频率的不成比例性分析.
- 接收器操作特征 (ROC) 分析确定了LEV:CBZ剂量比门.
主要成果:
- 同时服用LEV显著增加了CBZ毒性的几率 (几率比率=16.65).
- 1,86的LEV:CBZ剂量比被确定为区分有毒和非有毒CBZ度的门,准确度为72.9%.
- 单独使用CBZ剂量与毒性之间没有发现任何关联,但使用LEV与毒性水平有关.
结论:
- 在LEV给药和CBZ毒性之间存在时间关联.
- 当LEV:CBZ剂量比达到1.86时,CBZ毒性的风险显著增加.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
199
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
199
Antiepileptic Drugs: Potassium Channel Activators
136
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
136
Antiepileptic Drugs: GABAergic Pathway Potentiators
293
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
293
Antiepileptic Drugs: Sodium Channel Blockers
301
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
301
Antiepileptic Drugs: Calcium Channel Blockers
266
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
266
Antiepileptic Drugs: Glutamate Antagonists
260
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
260


